Evidence map›Paper›PMID 41463280›Full record

ReviewCancers2025

Would Biopsy Change the Management of Kidney Cancer in the Coming Decade? The Role of Biopsy in Small Renal Masses: A Narrative Review.

Łukasz Dariusz Lisak, Paweł Hełka, Aleksandra Kaźmierczak, Anna Kaletka, Sarah Sampers, Piotr Kania, Miłosz Jasiński, Maciej Salagierski

Abstract readReview
In one paragraph

Review in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Łukasz Dariusz LisakUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.ORCID 0009-0003-4241-5212
Paweł HełkaUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.
Aleksandra KaźmierczakUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.ORCID 0009-0000-0409-8680
Anna KaletkaUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.
Sarah SampersUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.
Piotr KaniaUrology Department, Mazovian Hospital, 08-110 Siedlce, Poland.ORCID 0000-0001-7275-2111
Miłosz JasińskiUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.ORCID 0000-0002-9665-9998
Maciej SalagierskiUrology Department, Collegium Medicum, University of Zielona Góra, 65-417 Zielona Góra, Poland.ORCID 0000-0001-8646-1219

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) is the 14th-most common cancer worldwide, with 434,419 new cases recorded in 2022 [...].

Indexed as

kidney cancerrenal cell carcinomarenal mass biopsyrenal tumor biopsy

Identifiers

PMID41463280
PMCPMC12731812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.